Ticker
AUTLCompany Name
AUTOLUS THERAPEUTICS PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -240.51M | -803.46% | $ 29.93M |
3/31/2025 | $ -234.21M | -2599.1% | $ 9.01M |
12/31/2024 | $ -209.84M | -2073.52% | $ 10.12M |
9/30/2024 | $ -187.54M | -1858.53% | $ 10.09M |
6/30/2024 | $ -161.93M | -1542.66% | $ 10.5M |
3/31/2024 | $ -157.89M | -1504.12% | $ 10.5M |
12/31/2023 | $ -163.34M | -9619.26% | $ 1.7M |
9/30/2023 | $ -157.26M | -2847.42% | $ 5.52M |
6/30/2023 | $ -158.56M | -2118.05% | $ 7.49M |
3/31/2023 | $ -162.28M | -2167.75% | $ 7.49M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Revenues
(=) EBIT %
EBIT % for AUTOLUS THERAPEUTICS PLC is calculated as follows: EBIT [ $ -162.58M ] / Revenues [ $ 1.62M ]
(=) EBIT % [ -10035.62% ]
Minimum
Jun 30, 2022
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.26K |
---|---|
min | -73.16% |
max | 83.08% |
average | 9.54% |
median | 9.01% |
std | 23.96% |